680 related articles for article (PubMed ID: 27688191)
1. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
2. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates.
Liu R; Fu Z; Zhao M; Gao X; Li H; Mi Q; Liu P; Yang J; Yao Z; Gao Q
Oncotarget; 2017 Jun; 8(24):39476-39496. PubMed ID: 28467806
[TBL] [Abstract][Full Text] [Related]
3. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects.
Han J; Gao X; Liu R; Yang J; Zhang M; Mi Y; Shi Y; Gao Q
Chem Biol Drug Des; 2016 Jun; 87(6):867-77. PubMed ID: 26706102
[TBL] [Abstract][Full Text] [Related]
5. Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
Li T; Gao X; Yang L; Shi Y; Gao Q
ChemMedChem; 2016 May; 11(10):1069-77. PubMed ID: 27135196
[TBL] [Abstract][Full Text] [Related]
6. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
[TBL] [Abstract][Full Text] [Related]
7. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
Wang H; Yang X; Zhao C; Wang PG; Wang X
Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
10. Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo.
Patra M; Awuah SG; Lippard SJ
J Am Chem Soc; 2016 Sep; 138(38):12541-51. PubMed ID: 27570149
[TBL] [Abstract][Full Text] [Related]
11. Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties.
Liu P; Lu Y; Gao X; Liu R; Zhang-Negrerie D; Shi Y; Wang Y; Wang S; Gao Q
Chem Commun (Camb); 2013 Mar; 49(24):2421-3. PubMed ID: 23420130
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
14. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery.
Ma J; Wang Q; Huang Z; Yang X; Nie Q; Hao W; Wang PG; Wang X
J Med Chem; 2017 Jul; 60(13):5736-5748. PubMed ID: 28603992
[TBL] [Abstract][Full Text] [Related]
15. Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1.
Liu R; Li H; Gao X; Mi Q; Zhao H; Gao Q
Biochem Biophys Res Commun; 2017 May; 487(1):34-40. PubMed ID: 28385528
[TBL] [Abstract][Full Text] [Related]
16. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
[TBL] [Abstract][Full Text] [Related]
17. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
18. Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo.
Ma J; Yang X; Hao W; Huang Z; Wang X; Wang PG
Eur J Med Chem; 2017 Mar; 128():45-55. PubMed ID: 28147308
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]